Related references
Note: Only part of the references are listed.Antiviral therapy for chronic hepatitis B viral infection in adults: A systematic review and meta-analysis
Anna S. F. Lok et al.
HEPATOLOGY (2016)
Combination of Tenofovir Disoproxil Fumarate and Peginterferon alpha-2a Increases Loss of Hepatitis B Surface Antigen in Patients With Chronic Hepatitis B
Patrick Marcellin et al.
GASTROENTEROLOGY (2016)
Historical review on thymosin α1 in oncology: preclinical and clinical experiences
Enrico Garaci et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2015)
Thymosin alpha-1 treatment in chronic hepatitis B
Xiaoning Wu et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2015)
Immunological Aspects of Antiviral Therapy of Chronic Hepatitis B Virus and Hepatitis C Virus Infections
Barbara Rehermann et al.
HEPATOLOGY (2015)
Management of chronic hepatitis B infection
Vinay Sundaram et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Management of chronic hepatitis B infection
Vinay Sundaram et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Optimal therapy for chronic hepatitis B: hepatitis B virus combination therapy?
Jorg Petersen et al.
LIVER INTERNATIONAL (2015)
Current and future directions for treating hepatitis B virus infection
Akinobu Tawada et al.
WORLD JOURNAL OF HEPATOLOGY (2015)
ADDING PEGINTERFERON TO ENTECAVIR INCREASES RESPONSE RATES IN HBeAg-POSITIVE CHRONIC HEPATITIS B PATIENTS: WEEK 96 RESULTS OF A GLOBAL MULTICENTER RANDOMISED TRIAL (ARES STUDY)
W. P. Brouwer et al.
JOURNAL OF HEPATOLOGY (2014)
Management of chronic hepatitis B infection: Current treatment guidelines, challenges, and new developments
Ceen-Ming Tang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Efficacy of thymosin α-1 plus peginterferon α-2a combination therapy compared with peginterferon α-2a monotherapy in HBeAg-positive chronic hepatitis B: A prospective, multicenter, randomized, open-label study
Bo Hyun Kim et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2012)
Serum HBsAg Levels During Peginterferon alpha-2a Treatment With or Without Thymosin alpha-1 in HBeAg-Positive Chronic Hepatitis B Patients
Eun Young Song et al.
JOURNAL OF MEDICAL VIROLOGY (2011)
Transcription profile of human lymphocytes following in vitro treatment with thymosin alpha-1
Claudia Matteucci et al.
THYMOSINS IN HEALTH AND DISEASE (2010)
Thymosin alpha 1: past clinical experience and future promise
Cynthia Tuthill et al.
THYMOSINS IN HEALTH AND DISEASE (2010)
From lab to bedside: emerging clinical applications of thymosin alpha(1)
Allan L. Goldstein et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2009)
Treatment with lamivudine versus lamivudine and thymosin alpha-I for e antigen-positive chronic hepatitis B patients: a meta-analysis
Yuan-Yuan Zhang et al.
VIROLOGY JOURNAL (2009)
Treatment with lamivudine versus lamivudine and thymosin alpha-1 for e antigen-positive chronic hepatitis B patients: a meta-analysis
Yuan-Yuan Zhang et al.
VIROLOGY JOURNAL (2009)
Comparison of the efficacy of thymosin alpha-1 and interferon alpha in the treatment of chronic hepatitis B: A meta-analysis
Yong-Feng Yang et al.
ANTIVIRAL RESEARCH (2008)
Efficacy of thymosin alpha-1 and interferon alpha in treatment of chronic viral hepatitis B: A randomized controlled study
Jing You et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2006)
Peginterferon alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B
GKK Lau et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Activation of IKK by thymosin α1 requires the TRAF6 signalling pathway
P Zhang et al.
EMBO REPORTS (2005)
Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B
P Marcellin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Thymosin α 1 activates dendritic cells for antifungal Th1 resistance through Toll-like receptor signaling
L Romani et al.
BLOOD (2004)
Long-term outcomes of thymosin-α1 and interferon α-2b combination therapy in patients with hepatitis B e antigen (HBeAg) negative chronic hepatitis B
M Saruc et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2003)
The efficacy of thymosin in the treatment of chronic hepatitis B virus infection: a meta-analysis
HLY Chan et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2001)
Share Paper
